To Switch or not to Switch to Long-acting Injectable Cabotegravir/Rilpivirine in PWH With Past Hepatitis B Virus (HBV) Coinfection: Which HBV Markers to Manage Risk of HBV Reactivation?.
Saved in:
| Title: | To Switch or not to Switch to Long-acting Injectable Cabotegravir/Rilpivirine in PWH With Past Hepatitis B Virus (HBV) Coinfection: Which HBV Markers to Manage Risk of HBV Reactivation?. |
|---|---|
| Authors: | Ollier, Laurence1 (AUTHOR), Monte, Anne De1 (AUTHOR), Thibault, Vincent2 (AUTHOR), Pugliese, Pascal3 (AUTHOR), Chirio, David3 (AUTHOR), Durant, Jacques3 (AUTHOR), Carles, Michel3,4 (AUTHOR), Naqvi, Alissa3 (AUTHOR) |
| Source: | Open Forum Infectious Diseases. Jun2025, Vol. 12 Issue 6, p1-4. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
